Early development of transient hypothyroidism after I131 therapy for thyrotoxicosis

Journal of Association of Physicians of India

Volumn 46, Issue 3, 1998, Pages 268-272

  Khanna, C M ^a   Sankar, R ^a   Magdum, M ^a   Gera, A ^a  

^a INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; RADIOACTIVE IODINE; THYROTROPIN; THYROXINE;

ARTICLE; BLOOD; FEMALE; GRAVES DISEASE; HUMAN; HYPOTHYROIDISM; MALE; MIDDLE AGED; THYROTOXICOSIS;

FEMALE; GRAVES DISEASE; HUMANS; HYPOTHYROIDISM; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; THYROTOXICOSIS; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 0032009103     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Bellabarba D, Bernard B, Langlois M. Pattern of serum thyroxine, triiodothyronine and thyrotropin after treatment of thyrotoxicosis. Clinical Endocrinology 1972; 1 : 345-53.
2. Chapman EM, Maloof F, Maisterrene J, Martin JM. Ten years experience with radioactive iodine. J Clin Endocrinol 1954; 14 : 45-55.
3. Dorfmann SG, Young RL, Carfetta R. Transient hypothyroidism. Arch Intern Med 1977; 137 : 256-7.
4. Kendall - Taylor P, Keir MJ, Ross WM. The evaluation of radioiodine therapy for hyperthyroidism. Br Med J 1984; 289 : 361-3.
5. Ratcliffe GE, Fogelman I, Maisey MN. The evaluation of radioiodine therapy for thyroid patients using a fixed dose regime. Br J Radiol 1986; 59 : 1105-7.
6. Toft AD, Irvine WJ, Hunter WM, Ratcliffe JG, Seth J. Anamolous plasma TSH levels in patients developing hypothyroidism in the early months after 1-131 therapy for thyrotoxicosis. J Clin Endocrinol Metab 1974; 39 : 607-9.
7. Sawers JSA, Toft AD, Irwine WJ, Brown NS, Seth J. Transient hypothyroidism after I-131 treatment of thyrotoxicosis. J Clin Endocrinol Meta 1980; 50 : 226-9.
8. Shalet SM, Mac Farlane JA, Beardwell CG. Patients at risk of hypothyroidism. Lancet 1977; 326 : 32.
9. Rosner B Fundamentals of biostatisticts. Duxbury Press Boston 1986; 326-32.
10. Kaplan EL, Meier P, Nonparameteric estimation from incomplete observations. J Am Stat Assoc 1958; 53 : 457-81.
11. Fraser R, Abatt, Stewart FS. Radioiodine treatment of thyrotoxicosis A Single dose method following a drag preparation. Br J Radiol 1954; 27 : 23-6.
12. Connell JMC, Hibbtch TE, McCruden DC, Alexander WD. Transient hypothyroidism following radioiodine therapy for thyrotoxicosis. Br J Radiol 1983; 56 : 309-13.
13. Peden NR, Hart IR. The early development of transient and permanent hypothyroidism following radioiodine therapy for hyperthyroid Graves' disease. Can Med Ass J 1984; 130 : 141-4.
14. Gomez JM, Virgili N, Soder T, Fernandex M, Montana E. Transient hypothyroidism after 1-131 treatment of Graves disease. Thyroidol Clin Exp 1989; 3 : 149-52.
15. Atkinson S, McGregor AM, Kendall Taylor P, Paterson MM, Smith BR. Effect of radioiodine on stimulatory activity of Graves' immunoglobulins. Clin Endocrinol (OXF) 1982; 6 : 537-41.
16. Kaise K, Kaise N. Yoshida K et al Thyrotropin receptor antibody activities significantly correlate with the outcome of radioiodine therapy for hyperthyroid Graves disease. Endocrinol Jpn 1991; 38 : 429-33.
17. Atkinson S, McGregor AM, Kendall-Taylor P, Paterson MM, Smith BR. Effect of radioiodine on stimulatory activity activity of Graves' disease. Immunoglobulins Clin Endocrinol (OXF) 1982; 6 : 537-41.
18. Kaise K, Kaise N, Yoshidak et al. Thyrotropin receptor antibody activities significantly correlate with the out come of radioiodine (I-131) Therapy for hyperthyroid Graves disease. Endocrinol Jpn 1991; 38 : 429-33.